Not finding it? Sign in to also search OpenAlex live.
-
Epcoritamab with rituximab + lenalidomide (R2) and epcoritamab maintenance deliver deep and durable remissions in previously untreated (1L) follicular lymphoma (FL): 3-year outcomes from epcore NHL-2 arms 6 and 7
Lori Ann Leslie, Gerardo Musuraca, Pau Abrisqueta, Joshua Brody, Jacob Haaber Christensen, Alexander Fosså, +8 more
2citations -
P690 Prolonged benefit of filgotinib in patients with Ulcerative Colitis in SELECTION2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
David Laharie, A Sturm, Taku Kobayashi, Takayuki Matsumoto, Alessandra Faria Oortwijn, C Jamoul, +2 more
1citations -
Analysis of the Impact of Body Mass Index (BMI) on the Durability of Response in Patients with Aplastic Anemia Treated with Weight-Adjusted Horse Anti-Thymocyte Globulin (hATG)
Jeanette Walter, Benjamin Rolles, Frauke Theis, Leo Hansmann, Daniel Heudobler, Markus Philipp Radsak, +10 more
0citations -
P-802 Unraveling a distinct role for GATA3 in mouse and human trophectoderm development via CRISPR/Cas9 gene editing2025 Human Reproduction conference-abstract Biochemistry, Genetics and Molecular Biology Pluripotent Stem Cells Research Open access
Sofie Declercq, Gwenny Cosemans, Tijs Vanhessche, Dominic Stoop, Susana M. Chuva de Sousa Lopes, Kim De Leeneer, +2 more
0citations -
Outcome of adult B-precursor acute lymphoblastic leukemia (ALL) treated with blinatumomab in addition to chemotherapy independent of MRD: First results from the national GMALL registry
Nicola Gökbuget, Matthias Stelljes, Walter Fiedler, Jens Panse, Andreas Viardot, Lisa Heberling, +14 more
0citations
6 results